Veteran Whistleblowers Advise Other Would-Be 'Ethical Resisters' To Carefully Weigh Personal Consequences Before Taking Action

A prominent committee of the National Academy of Sciences (NAS) advises beginning researchers that, if they suspect a colleague of violating the ethical standards of the scientific community, they have "an unmistakable obligation to act"--that is, to blow the whistle on the misconduct. VINDICATED BUT . . . Carolyn Phinney won $1.246 million in court; however, she suffered post-traumatic stress disorder and is now unemployed. Historically, however, many researchers who have tried to carry throu

Written byFranklin Hoke
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

A prominent committee of the National Academy of Sciences (NAS) advises beginning researchers that, if they suspect a colleague of violating the ethical standards of the scientific community, they have "an unmistakable obligation to act"--that is, to blow the whistle on the misconduct.


VINDICATED BUT . . . Carolyn Phinney won $1.246 million in court; however, she suffered post-traumatic stress disorder and is now unemployed.
Historically, however, many researchers who have tried to carry through on this "obligation" have lost their careers, been ostracized by their fellow scientists, and suffered intimidation, defamation, and reprisal at the hands of their employing institutions. Some who have studied whistleblowing call the academy's advice--given in On Being A Scientist: Responsible Conduct in Research, recently revised by the Committee on Science, Engineering, and Public Policy (Washington, National Academy Press, 1995)--facile, even irresponsible.

"That's a wonderful, ideal statement, but it's an unfortunate one, because it sets ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies